Medindia

X

Steven Galson, M.D., M.P.H. Joins SAIC As Senior Vice President for Civilian Health Operations

Tuesday, January 12, 2010 Corporate News J E 4
Advertisement


MCLEAN, Va. and SAN DIEGO, Jan. 11 Science Applications International Corporation (SAIC) (NYSE: SAI) today announced that former Acting U.S. Surgeon General, Steven Galson, M.D., M.P.H. has joined the company as Senior Vice President for Civilian Health Operations.

As part of SAIC's Health Solutions Business Unit, the Civilian Health Operation provides solutions to local, state, federal, and commercial health organizations to help prevent, prepare for, detect, and respond to public health threats. It also supports biomedical research and the advancement of life sciences in the healthcare market.

The operation has approximately 600 employees, with expertise in life sciences, health services, quantitative analysis, drug development, and commercial pharmaceutical regulatory compliance, as well as research and product development capabilities in areas such as cancer treatment, bio-threat analysis, and pre-clinical vaccines. The operation's work is primarily performed in Atlanta, Ga., and several locations in Maryland (Bethesda, Frederick, Fort Detrick, and Rockville).

In his new role, Galson will lead SAIC's civilian health team, manage the operation's long-term growth strategy, and help develop new solutions to meet the evolving business needs of SAIC's civilian, public health, and life sciences customers. Galson will report to Anthony Hess, Ph.D., SAIC senior vice president and business unit general manager.

"Steven is a well known and highly respected member of the international healthcare community," said Hess. "His knowledge and vast public health and health science expertise will be of tremendous benefit to our customers. We are excited to have Steven join the Health Solutions leadership team."

Prior to joining SAIC, Galson was the Acting Surgeon General of the United States. He also served as the Acting Assistant Secretary of Health, and the Director of the Food and Drug Administration's Center for Drug Evaluation and Research. Galson also held executive positions in the U.S. Environmental Protection Agency, U.S. Department of Energy, and the Centers for Disease Control and Prevention's National Institute for Occupational Safety and Health.

Galson is a graduate of the State University of New York at Stony Brook where he earned a Bachelor of Science degree in biochemistry. He later earned a Doctor of Medicine degree from the Mt. Sinai School of Medicine, and a Master of Public Health degree from the Harvard School of Public Health. A retired rear admiral from the U.S. Public Health Service Commissioned Corps, Galson is also board certified in general preventive medicine, public health, and occupational medicine.

About SAIC

SAIC is a FORTUNE 500(® )scientific, engineering, and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. The company's approximately 45,000 employees serve customers in the U.S. Department of Defense, the intelligence community, the U.S. Department of Homeland Security, other U.S. Government civil agencies and selected commercial markets. Headquartered in McLean, Va., SAIC had annual revenues of $10.1 billion for its fiscal year ended January 31, 2009. For more information, visit www.saic.com. SAIC: From Science to Solutions(®)

Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in SAIC's Annual Report on Form 10-K for the period ended January 31, 2009, and other such filings that SAIC makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.

Contact: Melissa Koskovich Laura Luke (703) 676-6762 703-676-6533 melissa.l.koskovich@saic.com laura.luke@saic.com

SOURCE SAIC
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
VELOCITY Broadcasting Injects ROI into Pharmaceuti...
S
FitnessMagazine.com Inspires Holiday Splurgers to ...